PubMed COVID-19 Clinical Care

CONCLUSION: It may be difficult to use clinical characteristics to distinguish between patients with COVID-19 having malaria-like symptoms. Detection of IgM using RDTs may be useful in predicting CT values for SARS-CoV-2 real-time PCR and therefore

Lung transplant (LTx) recipients are at high risk for COVID-19 related morbidity and mortality. Data regarding pre-exposure prophylaxis (PrEP) with tixagevimab-cilgavimab in this population are scarce. We therefore evaluated COVID-19 breakthrough

In conventional randomized controlled trials, adjustment for baseline values of covariates known to be at least moderately associated with the outcome increases the power of the trial. Recent work has shown a particular benefit for more flexible

CONCLUSION: We identified four ^(129)XeMRI long COVID phenotypes with distinct characteristics. ^(129)XeMRI can dissect pathophysiologic heterogeneity of long COVID to enable personalised patient care.

The decreasing efficacy of antiviral drugs due to viral mutations highlights the challenge of developing a single agent that effectively target multiple viral strains. One promising approach to this problem is to use host cell viral receptors as

While Coronavirus Disease in 2019 (COVID-19) may no longer be classified as a global public health emergency, it still poses a significant risk at least due to its association with thrombotic events. This study aims to reaffirm our previous

No abstract

No abstract

CONCLUSION: The majority of the community pharmacists exhibited a positive perception and are willing to practice the concept of telepharmacy despite having a below average knowledge of telepharmacy. A future study involving the entire kingdom of

CONCLUSIONS: This review found no increased risk of severe outcomes in CAD and COVID-19 patients treated with rituximab.